108 related articles for article (PubMed ID: 11369120)
1. Color Doppler ultrasound in breast carcinomas: relationship with hormone receptors, DNA ploidy, S-phase fraction, and histopathology.
Chao TC; Luo YF; Chen SC; Chen MF
Ultrasound Med Biol; 2001 Mar; 27(3):351-5. PubMed ID: 11369120
[TBL] [Abstract][Full Text] [Related]
2. Sonographic blood flow measurements in malignant breast tumors. A potential new prognostic factor.
Sohn C; Beldermann F; Bastert G
Surg Endosc; 1997 Sep; 11(9):957-60. PubMed ID: 9294282
[TBL] [Abstract][Full Text] [Related]
3. Color Doppler ultrasound in benign and malignant breast tumors.
Chao TC; Lo YF; Chen SC; Chen MF
Breast Cancer Res Treat; 1999 Sep; 57(2):193-9. PubMed ID: 10598046
[TBL] [Abstract][Full Text] [Related]
4. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
5. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
6. Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival.
Peters-Engl C; Frank W; Leodolter S; Medl M
Breast Cancer Res Treat; 1999 Mar; 54(1):65-71. PubMed ID: 10369082
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound.
Hsieh CY; Wu CC; Chen TM; Chen CA; Chen CL; Wang JF; Chang CF; Hsieh FJ
Cancer; 1995 May; 75(10):2518-22. PubMed ID: 7736396
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
[TBL] [Abstract][Full Text] [Related]
10. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
[TBL] [Abstract][Full Text] [Related]
11. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer vascularity: color Doppler sonography and histopathology study.
Lee WJ; Chu JS; Huang CS; Chang MF; Chang KJ; Chen KM
Breast Cancer Res Treat; 1996; 37(3):291-8. PubMed ID: 8825140
[TBL] [Abstract][Full Text] [Related]
13. New signs of breast cancer: high resistance flow and variations in resistive indices evaluation by color Doppler sonography.
Hollerweger A; Rettenbacher T; Macheiner P; Gritzmann N
Ultrasound Med Biol; 1997; 23(6):851-6. PubMed ID: 9300988
[TBL] [Abstract][Full Text] [Related]
14. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
[TBL] [Abstract][Full Text] [Related]
15. Pathology and behavior of small breast carcinomas.
Meyer JS; Fahrner M; Daniel FC
Semin Diagn Pathol; 1999 Aug; 16(3):257-68. PubMed ID: 10490202
[TBL] [Abstract][Full Text] [Related]
16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
[TBL] [Abstract][Full Text] [Related]
18. Correlation among intratumoral blood flow in breast cancer, clinicopathological findings and Nottingham Prognostic Index.
Osanai T; Wakita T; Gomi N; Takenaka S; Kakimoto M; Sugihara K
Jpn J Clin Oncol; 2003 Jan; 33(1):14-6. PubMed ID: 12604718
[TBL] [Abstract][Full Text] [Related]
19. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
[TBL] [Abstract][Full Text] [Related]
20. Expression of the 85-kd membrane protein in primary human breast cancer: relationship to hormone receptor levels, DNA ploidy, and tumor grade.
de la Torre M; Nygren P; Larsson R; Lindgren A; Tsuruo T; Bergh J
Hum Pathol; 1995 Feb; 26(2):180-5. PubMed ID: 7532148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
